Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

07/03/2022 14:30

Jaguar Health to Host Investor Webcast Monday, March 14th at 8:30 AM Eastern Time Regarding Q4 2021 Financials & Corporate Updates

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

01/03/2022 14:30

Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, March 6th, During the Western Veterinary Conference (WVC) in Las Vegas

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

16/02/2022 14:30

Jaguar Animal Health Seeks MUMS Designation from FDA for Canalevia (Crofelemer) for Treatment of Exercise-induced Diarrhea (EID) in Dogs

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

15/02/2022 14:30

Jaguar Health Announces Receipt by Napo Therapeutics of Small and Medium Enterprise (SME) Designation from the European Medicines Agency

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

10/02/2022 14:30

Jaguar Health Completes Final Major Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea in Dogs

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

01/02/2022 14:30

Jaguar Health Announces Completion of Third-party, Investigator-Initiated Study of Crofelemer, which is Expected to Support Orphan Drug Designation (ODD) for Crofelemer for Congenital Diarrheal Disorders (CDD)

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

24/01/2022 14:30

Jaguar Health Announces Appointment of Martire Particco, MD, as Chief Medical Officer of Napo Therapeutics

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

13/01/2022 14:30

Jaguar Health Provides Corporate Update and Outlines 2022 Milestones

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

12/01/2022 14:30

Jaguar Animal Health to Host Treatment Forum for Veterinarians About Chemotherapy-Induced Diarrhea (CID) in Dogs on Sunday, January 16th During the Veterinary Meeting & Expo (VMX) Conference in Orlando, Florida

Voir tous les communiqués de Jaguar Health, Inc.

JAGUAR HEALTH, INC. (NASDAQ:JAGX)

04/01/2022 14:30

Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Voir tous les communiqués de Jaguar Health, Inc.

«
1
2
3
4
5
»